Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Relay Therapeutics Inc (NQ: RLAY ) 8.355 +0.085 (+1.03%) Streaming Delayed Price Updated: 10:14 AM EDT, Jul 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Relay Therapeutics Inc < Previous 1 2 3 4 5 Next > Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... Via Talk Markets Clinical-Stage BioTech Drug Stocks Declined 13% In June July 01, 2024 Our BioTech Drug Stocks Portfolio was DOWN 13.2% in June. Before proceeding read Via Talk Markets Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th June 17, 2024 The global Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week June 10, 2024 The global Via Talk Markets Expert Ratings For Relay Therapeutics June 07, 2024 Via Benzinga Key Takeaways From Relay Therapeutics Analyst Ratings May 10, 2024 Via Benzinga Relay Therapeutics: Q4 Earnings Insights February 22, 2024 Via Benzinga Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week May 27, 2024 This article highlights the performances last week and MTD of the 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies along with their areas of focus in our... Via Talk Markets 5 Of 7 AI Categories Rose, Slightly,Over Past Week May 11, 2024 The 7 AI categories we track went up marginally (1.0%, on average) the second week of May, after having gone down 0.4% the previous week. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence The 7 AI Categories Declined, On Average, The First Week Of May May 05, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May May 05, 2024 We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD. Via Talk Markets RLAY Stock Earnings: Relay Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 RLAY stock results show that Relay Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Relay Therapeutics's Earnings: A Preview February 21, 2024 Via Benzinga Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week April 23, 2024 A look at the 10 clinical-stage AI-powered and psychedelic compound-based small-cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, their stock performances last week and... Via Talk Markets 12 Health Care Stocks Moving In Wednesday's After-Market Session April 10, 2024 Via Benzinga AI Surge Ending: Only One Category Was Up This Week April 06, 2024 Six of the 7 categories we cover dropped this week, compared with 3 in March. The data clearly indicates that the surge in this sector is stalling or perhaps is even over. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence 3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise March 15, 2024 Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities. Via InvestorPlace AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD March 04, 2024 Grand View Research says the global Via Talk Markets AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics February 19, 2024 The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence The 7 Best Penny Stocks for 200% Returns February 06, 2024 Penny stocks often possess significant upside and these are no different with 200% returns expected by analysts. Via InvestorPlace AI-Focused Drug Discovery Stocks Index Up 26% In December December 29, 2023 With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. Via Talk Markets AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week December 17, 2023 A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Earnings Scheduled For February 22, 2024 February 22, 2024 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 13, 2023 Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Relay Therapeutics: Here's What You Need To Know December 11, 2023 Via Benzinga The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week December 11, 2023 If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to... Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November December 06, 2023 The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence November 09, 2023 We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Earnings Scheduled For November 2, 2023 November 02, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.